Anti-lipid trial endpoints.
Orloff
D G
DG
Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Rockville, MD 20857, USA.
D000367:Age Factors; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000150:complications / Q000517:prevention & control*; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006937:Hypercholesterolemia / Q000150:complications / Q000188:drug therapy*; D008297:Male; D012008:Recurrence; D012307:Risk Factors; D012737:Sex Factors
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors